[PDF] Top 20 LA AGENCIA OFICIOSA EN EL NUEVO CÓDIGO GENERAL DEL PROCESO

... Patients enrolled received neoadjuvant 3 cycles of Gemcitabine/Cisplatin, each cycle was every 21 days. Gemcitabine at 1000mg/m 2 on days 1&8 and cisplatin at 70mg/m 2 on day1, followed by Concurrent chemordiotherapy ... See full document

... surgical therapy for MIBC, TMT can also be offered to select patients who seek bladder ...multidisciplinary bladder cancer clinic yielded moderate-term disease-specif- ic survival rates ... See full document

... 179 invasive bladder cancer patients treated with definitive radiotherapy at 55 Gy (hazard ratio [HR] ...157 invasive bladder cancer patients undergoing cisplatin-based ... See full document

... for muscle-invasive bladder cancer (MIBC), in octogenarians cystec- tomy results in a higher perioperative mortality rate ...(2.2%). Trimodality therapy is a bladder- ... See full document

... All the cryosurgery procedures were performed success- fully and all patients well tolerated with the transperineal cryosurgery, and with minimal requirements for pain medication and without the need for blood ... See full document

... decreased invasive local recurrence by nearly 50% when compared to radiotherapy ...functional bladder while avoiding the use of cisplatin-based therapy, which is often not an option for patients who ... See full document

... Muscle-invasive bladder cancer is a heterogeneous disease with an overall poor prognosis ...a bladder preservation strategy is being pursued, chemoradiation may be offered as ... See full document

... The BEXIDEM dose and regimen used in the study were based on prior phase I experience [26]. Patients ran- domized to BEXIDEM had mononuclear cells and plasma collected by apheresis of peripheral blood and shipped ... See full document

... Descriptive statistics were used to summarize patient characteristics and outcomes. The Kaplan-Meier method was used to estimate time-to-event outcomes, including the primary outcome of overall survival (OS, defined as ... See full document

... matched samples the study might be underpowered to show statistically significant differences. For example, number of positive nodes and diameter of the metastatic deposits both appeared to show a relationship to FGFR3 ... See full document

... for cancer cell stemness, we hypothesize that targeting TGFβ1 pathway may reduce CSC population and enhance efficacy of ...culturing cancer cells from four different T24 xenograft groups, we found that, ... See full document

... One patient (7.1%) had a complete response (CR) proved by CT scan & cystoscope evaluation. Four (28.6%) patients have a partial response (PR). Five (35.7%) patients obtained stable disease (SD) and 4 (28.6%) patients ... See full document

... ish Cancer Society for their financial support; other board members in DaBlaCa-data: Niels Viggo Jensen, Anette Pedersen Pilt, Knud Fabrin; Elin Kallestrup, representative of the data controlling authority; and ... See full document

... BCG therapy with patients who received radical surgery after 2 years; early radical cystec- tomy was associated with significantly improved survival in patients with non-muscle invasive recurrence as ... See full document

... thromboembolism during NAC, NAC-related mortality and the non-selective nature of NAC. Countering these concerns is the randomized nature of the trials supporting NAC which, by definition, already account for ... See full document

... We illustrated some of the diagnostic and treatment related issues related to MIBC, specifically the need to investigate hematuria in the right clinical context and to offer neoadju- vant cisplatin based chemotherapy to ... See full document

... suspected bladder per- foration or deep/extensive resection should not receive an immediate instillation, as severe complications have been reported in this ... See full document

... alone and the other group receiving sequential BCG and electromotive MMC. Both groups received induction and maintenance therapy. At a mean follow-up of 88 months, patients treated with BCG plus electromotive MMC ... See full document

... which could protect the patient against suffering poor prog- nosis via aiding in rational clinical decision-making during the earlier status. Over the past few decades, the great efforts have been made in elucidating the ... See full document

... had invasive bladder tumor subjected to radical ...of invasive TCC of the bladder with good ...Organ preservation in Bilharzial bladder is still ... See full document